Comparing the Effects of Psilocin and Psilocybin in Healthy Adults

StatusUnknown
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Primary completion date changed from estimate of Mar 2025 to Jan 16, 2025
    • Study completion date: Mar 2025 to Jul 2025
    v8
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    • Publications: 8 to 6
    v7
  4. Primary and study completion dates: Dec 2024 to Mar 2025
    • Site contact updated
    v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Eligibility criteria shortened, about 34 words
    • Collaborators expanded, about 3 words
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 2022 to May 26, 2022
    v3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To compare the physiological and psychological effects of psilocin taken orally by pill or sublingually by dissolving a tablet under the tongue to those of psilocybin taken by pill in healthy adults.
Trial Details
NCT Number NCT05317689
Lead Sponsor University of California, San Francisco
Collaborators: Filament Health Corp.
Conditions
(from sponsor)		 Healthy
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov